Quanta Aesthetic Lasers USA, LLC – FDA Warning Letter
On June 16, 2012, the FDA issued a Warning Letter to Quanta Aesthetic Lasers USA, LLC, regarding their Quanta System Q-Plus T device. The FDA's review of the firm's website, www.quantausa.com, revealed that the device was being marketed for unapproved indications and with unapproved modifications.
The Quanta System Q-Plus T (K073549) was cleared for specific indications including treatment of vascular lesions, pigmented lesions, hair and tattoo removal, and soft tissue incision/excision/ablation/vaporization using Nd:YAG (1064nm, 532nm) and Ruby (694nm) lasers.
However, the firm's website promoted the device for "skin rejuvenation," "skin lifting," "skin tightening/smoothness," "acne treatments," "anti-aging," "firming," and "treatment of scars and keloids." These claims represent a major change in intended use, potentially affecting safety and effectiveness. Consequently, the device is adulterated under section 501(f)(1)(B) of the Act (21 U.S.C. § 351(f)(1)(B)) for lacking required premarket approval (PMA) or investigational device exemption (IDE). It is also misbranded under section 502(o) (21 U
- Product type
- Devices
ID · edf07831-f907-4690-b8ca-a54282d36232
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.